Publicacións en colaboración con investigadores/as de Russian Academy of Sciences (25)

2024

  1. Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence

    Biomolecules, Vol. 14, Núm. 3

  2. Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity

    Journal of Translational Medicine, Vol. 22, Núm. 1

2023

  1. Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer's Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

  2. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  3. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

2022

  1. Is NMDA‐Receptor‐Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?

    Journal of Clinical Medicine, Vol. 11, Núm. 3

  2. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Patients with minimal hepatic encephalopathy show altered thermal sensitivity and autonomic function

    Journal of Clinical Medicine, Vol. 10, Núm. 2, pp. 1-18

2020

  1. A look into liver mitochondrial dysfunction as a hallmark in progression of brain energy crisis and development of neurologic symptoms in hepatic encephalopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

  2. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

  3. The erythrocytic hypothesis of brain energy crisis in sporadic Alzheimer disease: Possible consequences and supporting evidence

    Journal of Clinical Medicine, Vol. 9, Núm. 1

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus

    Scientific Reports, Vol. 8, Núm. 1

  3. Metabolic abnormalities of erythrocytes as a risk factor for Alzheimer's disease

    Frontiers in Neuroscience, Vol. 11, Núm. JAN

2017

  1. Portacaval shunting causes differential mitochondrial superoxide production in brain regions

    Free Radical Biology and Medicine, Vol. 113, pp. 109-118

  2. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy

    PLoS ONE, Vol. 12, Núm. 10

2008

  1. Encapsulation of glutamine synthetase in mouse erythrocytes: A new procedure for ammonia detoxification

    Biochemistry and Cell Biology, Vol. 86, Núm. 6, pp. 469-476

2007

  1. Acute ammonia neurotoxicity in vivo involves increase in cytoplasmic protein P53 without alterations in other markers of apoptosis

    Journal of Neuroscience Research, Vol. 85, Núm. 11, pp. 2491-2499

  2. Apoptotic markers in the mitochondria, cytosol, and nuclei of brain cells during ammonia toxicity

    Neurochemical Journal, Vol. 1, Núm. 1, pp. 78-85

  3. NMDA receptors in hyperammonemia and hepatic encephalopathy

    Metabolic Brain Disease